Beaumont seeks participants for a research study of a cartilage tissue implant for knee injuries

Beaumont Health System is participating in a research study evaluating an investigational treatment called NeoCart®, a tissue implant made from a patient’s own cells, aimed at repairing certain knee cartilage injuries. A total of 245 patients will participate in the research of the surgical implant procedure in up to 40 sites across the United

Beaumont Hospital, Troy opens brachytherapy program to treat cancer

Internal radiation therapy allows for higher total dose over a shorter period Beaumont Health System’s Radiation Oncology department is expanding its brachytherapy program with a new location at Beaumont Hospital, Troy. The new site and its multidisciplinary medical team treat patients with breast, cervical, uterine, vaginal, head and neck and

Beaumont named to 2014 InformationWeek Elite 100 technology innovators

Beaumont Health System has once again been named among the nation's most innovative users of business technology. The 2014 InformationWeek Elite100 – a list of the top business technology innovators in the U.S. – can be found on http://www.informationweek.com/elite100. Beaumont is the only health system in Michigan named to the list, and one of

The Ted Lindsay Foundation donates $1 million to help children with autism at Beaumont Children’s Hospital

In conjunction with World Autism Day, the Ted Lindsay Foundation is donating $1 million to expand and create a new facility for the HOPE Center, which provides Hands-On Parent Education (HOPE) to families of children with autism spectrum disorders and other developmental disorders.

Beaumont Researchers: Biomarkers predict effectiveness of radiation treatments for head and neck cancer

An international team of researchers, led by Beaumont Health System’s Jan Akervall, M.D., Ph.D., looked at biomarkers to determine the effectiveness of radiation treatments for patients with squamous cell cancer of the head and neck. They identified two markers that were good at predicting a patient’s resistance to radiation therapy. Their